George W. Lloyd

Insider Reports History

Identity
Location
New York, NY
SEC record
Reporting signature
/s/ Sean Weisberg, as Attorney-in-Fact for George W. Lloyd
SEC evidence
Transaction evidence
Report rows are grouped by the transaction date disclosed in the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Holdings reported by George W. Lloyd:

Form 4 holding EVP, Investments & CLO

Royalty Pharma plc

Security class
LP interests in RPI US Partners 2019, LP
Shares / value
291,739
Estimated value
$104,559,257
Report date
06 Aug 2025
Price
$358.40
Ownership
By GWL 2014 G, LLC
Underlying class
Class A Ordinary Shares
Underlying amount
2,917,390
Form 4 holding EVP, Investments & CLO

Royalty Pharma plc

Security class
LP interests in RPI US Partners 2019, LP
Shares / value
272,672
Estimated value
$97,725,644
Report date
06 Aug 2025
Price
$358.40
Ownership
By GWL 2020 G, LLC
Underlying class
Class A Ordinary Shares
Underlying amount
2,726,720
Form 4 holding EVP, Investments & CLO

Royalty Pharma plc

Security class
LP interests in RPI US Partners 2019, LP
Shares / value
130,148
Estimated value
$46,645,043
Report date
06 Aug 2025
Price
$358.40
Ownership
By GWL 2021 G LLC
Underlying class
Class A Ordinary Shares
Underlying amount
1,301,480
Form 4 holding EVP, Investments & CLO

Royalty Pharma plc

Security class
LP interests in RPI US Partners 2019, LP
Shares / value
58,173
Estimated value
$20,849,203
Report date
06 Aug 2025
Price
$358.40
Ownership
By GWL 2013 NG, LLC
Underlying class
Class A Ordinary Shares
Underlying amount
581,730
Form 4 holding EVP, Investments & CLO

Royalty Pharma plc

Security class
LP interests in RPI US Partners 2019, LP
Shares / value
0
Estimated value
$0
Report date
08 Aug 2025
Price
$358.40
Ownership
Direct
Underlying class
Class A Ordinary Shares
Underlying amount

Insider Reports Filed by George W. Lloyd

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .